MATERIALS AND METHODS

Chemistry: All the tested compounds were confirmed by physical and spectroscopic evidences according to the previously reported procedures (Amr et al., 2005).

Pharmacological activities
Experimental animals: All animals were obtained from National Research Center, Cairo, Egypt, Giza, Egypt and were acclimatized for 10 days under standard housing conditions (24±1°C; 45-55% RH with 12:12 h light/dark cycle). The animals had free access to rat food and water. The animals were habituated to laboratory conditions for 48 h prior to the experimental protocol to minimize any nonspecific stress. Animals were maintained under standard conditions in the animal house approved by Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA).

Cotton pellet-induced granuloma bioassay: The experimental method which was used in cotton pellet-inducedgranuloma bioassay has been adopted from Bekhit et al. (2008).

Carrageenan-induced rat paw edema: The experimental method which was used in carrageenan-induced rat paw edema has been adopted from Di Rosa and Willoughby (1971).

Human COX-1 and COX-2 enzymatic assay: Human COX-1 and COX-2 activities were determined as described by Wakitani et al. (1998).

Fig. 1:	Structures of celecoxib and reported active pyrazole derivatives

Ulcerogenic effects: All target compounds were evaluated for their ulcerogenic potential in rats (Abouzeit-Har et al., 1982).

Human, rat and dog microsomal COX assays: The experimental method which was used in human, rat and dog microsomal COX assay bioassay has been adopted from Chan et al. (1999).

Acute toxicity: The oral acute toxicity of compounds was investigated using male mice (20 g) according to previously reported methods (Verma et al., 1994; Litchfield and Wilcoxon, 1949). The animals were divided into groups of six mice each. The compounds were given orally, suspended in 1% gum acacia, in doses of 1, 10, 100, 200, 250 and 300 mg kg^–1. The mortality percentage in each group was recorded after 24 h. Additionally, the test compounds were investigated for their parenteral acute toxicity in groups of six mice each as reported earlier (Bekhit and Fahmy, 2003). The compounds, or their vehicle propylene glycol (control), were given by intraperitoneal injection in doses of 10, 25, 50, 75 and 100 mg kg^–1. The percentage survival was followed up to seven days (Bekhit and Fahmy, 2003).

Statistical analysis: Results are expressed as Mean±SEM. Differences between vehicle control and treatment groups were tested using one-way analysis ANOVA, followed by multiple comparisons by the Dunnett’s test. A value of p≤0.005 was considered statistically significant. Dose-response curves for percent protection and ulceration were fitted by a four-parameter logistic function using a nonlinear least-squares regression.

RESULTS AND DISCUSSION

Chemistry: Herein a series of spiroalkanones, pyrimidine and thiopyrimidine heterocyclic derivatives 1-10 (Fig. 2) were synthesized and illustrated by physical, chemical and spectroscopic evidences before and screened as analgesic, anticonvulsant and antiparkinsonian agents (Amr et al., 2005). In this study, we report the activities of these compounds as antiinflammatory agents.

Pharmacological activities: A series of substituted pyrimidines synthesized and screened for selective COX-2 inhibitors (Tietz et al., 2013).

Fig. 2:	Chemical structure of the tested compounds (1-10)

Table 1:	Anti-inflammatory activity (ED50 mmol) and ulcerogenic activity
Values were calculated from the mean values of data from three separate experiments and presented as Mean±SEM. All results are significant different from control values at p≤0.005. All results are significant different from reference standard values at p≤0.005

Table 2:	Effects of tested compounds on carrageenan-induced rat paw edema (mL), percentage protection and activity relative to indomethcin
Values were calculated from the mean values of data from three separate experiments and presented as Mean±SEM. All results are significant different from control values at p≤0.005. All results are significant different from reference standard values at p≤0.005

Many thiazolopyrimidines was synthesised and have potent anti-inflammatory activities and some of them showed potent antipyretic activities (Myakushkene et al., 1999). On the other hand, some of pyrimidine derivatives were synthesized and have been potent anti-inflammatory activities (Sondhi et al., 2001, 1999, 2000).

Pharmacological activities
Anti-inflammatory activities: Determination of the antiiflammatory activities via two animal models the firest was determintining the ED₅₀ that induce antiinflammatory activities using cotton pellet-induced granuloma bioassay (Table 1), all the tested compounds showed excellent anti-inflammatory activity and the order of activity was 8 (ED₅₀ = 1.56 μmol), 7 (ED₅₀ = 1.61 μmol), 9 (ED₅₀ = 1.67 μmol), 10 (ED₅₀ = 1.71 μmol), 2 (ED₅₀ = 1.77 μmol), 6 (ED₅₀ = 1.81 μmol), 1 (ED₅₀ = 1.83 μmol), 5 (ED₅₀ = 1.85 μmol), 4 (ED₅₀ = 1.88 μmol) and 3 (ED₅₀ = 1.98 μmol). All tested compounds were more active than indomethacin (ED₅₀ = 9.568 μmol).

The second one involving determination of increasing in paw edema by using carrageenan-induced rat paw edema (Table 2). All the tested compounds showed excellent protection against carrageenan-induced rat paw edema and the decending order of activity was 8 (protection, 87.85%), 7 (protection, 86.84%), 9 (protection, 85.83%), 10 (protection, 83.81%), 2 (protection, 83.81%), 6 (protection, 82.79%), 1 (protection, 80.77%), 5 (protection, 76.72%), 4 (protection, 75.71%) and 3 (protection, 68.62%). All tested compounds were more active than indomethacin (protection, 74.49%). The results obtained by carrageenan-induced rat paw edema considered as a good evidence toll that confirmed the results obtained by the cotton pellet-induced granuloma bioassay.

Ulcerogenic activities: Compounds 1 (ulceration, 0.00%), 3 (ulceration, 0.00%), 4 (ulceration, 0.00%), 5 (ulceration, 0.00%) and 6 (ulceration, 0.00%) was devoided from ulcerogenic activities, while other showed low ulcerogenic activities. Compounds 2 (ulceration, 5.44%), 7 (ulceration, 7.43%), 8 (ulceration, 8.45%), 9 (ulceration, 6.23%) and 10 (ulceration, 6.18%) causing minor ulceration while indomethacin causing 100% ulceration. It was oserved that as the antiinflammatory activities increases the ulcerogenic activities increases (Table 1).

In vitro human COX-2a and COX-1b enzymes inhibitory activities: In vitro human COX-2a and COX-1b enzymes inhibitory activities of compounds revealed that the tested compounds inhibited both COX-2a and COX-1b enzymes but greatly on COX-2a enzyme more than COX-1b enzyme (Table 3). The selectivity ratio COX-2/COX-1 was determined and was in the following desceniding selectivity order 8 (COX-2/COX-1 selectivity ratio: 1058.333), 7 (COX-2/COX-1 selectivity ratio: 921.429), 9 (COX-2/COX-1 selectivity ratio: 835.294), 10 (COX-2/COX-1 selectivity ratio: 835.000), 2 (COX-2/COX-1 selectivity ratio: 890.476), 6 (COX-2/COX-1 selectivity ratio: 792.000), 1 (COX-2/COX-1 selectivity ratio: 748.148), 5 (COX-2/COX-1 selectivity ratio: 731.034), 4 (COX-2/COX-1 selectivity ratio: 740.000) and 3 (COX-2/COX-1 selectivity ratio: 825.806). Compounds 8, 7, 9, 10, 2, 6, 1 and 5 were more active than celecoxi compound 4 equally active to celecoxib while, compound 3 less active than celecoxib (COX-2/COX-1 selectivity ratio: 333.333).

Table 3:	In vitro human COX-2a and COX-1b enzymes inhibitory activities of compounds
Values were calculated from the mean values of data from three separate experiments and presented as Mean±SEM. All results are significant different from control values at p≤0.005. All results are significant different from reference standard values at p≤0.005

Table 4:	Effect of compounds on human, dog and rat microsomal COX activities
Values were calculated from the mean values of data from three separate experiments and presented as Mean±SEM. All results are significant different from control values at p≤0.005. All results are significant different from reference standard values at p≤0.005

Table 5:	Acute toxicity of compounds (1-10)
Values were calculated from the mean values of data from three separate experiments and presented as Mean±SEM. All results are significant different from control values at p≤0.005

Effect of compounds on human, dog and rat microsomal COX activities: In human, dog and rat kidney microsome preparations (COX-1), celecoxib was substantially less potent than all the tested compounds and the order was as follow 8, 7, 9, 10, 2, 6, 1, 5, 43 and celecoxib (Table 4).

Acute toxicity: All tested compounds showed high LD₅₀ mainly above 2 g kg^–1. These high LD₅₀ ensure high sfety and go theraputic windows (Table 5).

CONCLUSION

Carfull examination of the relation between chemicall structure and apharmacological activities cualminated on the following assumptions.

Structure activity relationship;

ACKNOWLEDGMENT

The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project No. RGP-0172.